These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9761127)
1. Cytosol concentrations of CD44 isoforms in breast cancer tissue. Hefler L; Tempfer C; Haeusler G; Kucera E; Mayerhofer K; Zeillinger R; Reinthaller A; Kainz C Int J Cancer; 1998 Oct; 79(5):541-5. PubMed ID: 9761127 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Tempfer C; Lösch A; Heinzl H; Häusler G; Hanzal E; Kölbl H; Breitenecker G; Kainz C Eur J Cancer; 1996 Oct; 32A(11):2023-5. PubMed ID: 8943691 [TBL] [Abstract][Full Text] [Related]
3. CD44 is an independent prognostic factor in early-stage cervical cancer. Speiser P; Wanner C; Tempfer C; Mittelböck M; Hanzal E; Bancher-Todesca D; Gitsch G; Reinthaller A; Kainz C Int J Cancer; 1997 Apr; 74(2):185-8. PubMed ID: 9133453 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of CD44 isoform expression in endometrial cancer. Tempfer C; Haeusler G; Kaider A; Hefler L; Hanzal E; Reinthaller A; Breitenecker G; Kainz C Br J Cancer; 1998 Apr; 77(7):1137-9. PubMed ID: 9569051 [TBL] [Abstract][Full Text] [Related]
5. Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer. Kawano T; Yanoma S; Nakamura Y; Ozeki A; Kokatsu T; Kubota A; Furukawa M; Tsukuda M Acta Otolaryngol; 2005 Apr; 125(4):392-7. PubMed ID: 15823810 [TBL] [Abstract][Full Text] [Related]
6. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas. Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106 [TBL] [Abstract][Full Text] [Related]
7. [The cytosolic hyaluronic acid level defines several clinico-biological properties of CD44v5-positive infiltrating ductal carcinoma of the breast]. Ruibal A; Arias JI; Carmen del Río M; San Román JM; Lapeña G; Schneider J; Tejerina A Med Clin (Barc); 2000 Jul; 115(6):201-7. PubMed ID: 11002457 [TBL] [Abstract][Full Text] [Related]
8. Soluble CD44 splice variants and pelvic lymph node metastasis in ovarian cancer patients. Stickeler E; Vogl FD; Denkinger T; Mobus VJ; Kreienberg R; Runnebaum IB Int J Mol Med; 2000 Nov; 6(5):595-601. PubMed ID: 11029531 [TBL] [Abstract][Full Text] [Related]
9. CD44 splice variants as prognostic markers in colorectal cancer. Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913 [TBL] [Abstract][Full Text] [Related]
10. CD44v6 is not a prognostic factor in primary breast cancer. Jansen RH; Joosten-Achjanie SR; Arends JW; Volovics A; Hupperets PS; Schouten HC; Hillen HF Ann Oncol; 1998 Jan; 9(1):109-11. PubMed ID: 9541692 [TBL] [Abstract][Full Text] [Related]
11. CD44v6 expression in primary breast carcinoma in western India: a pilot clinicopathologic study. Shah NG; Trivedi TI; Vora HH; Patel KC; Tankshali R; Goswami JV; Shukla SN; Shah PM Tumori; 2010; 96(6):971-7. PubMed ID: 21388061 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer. Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528 [TBL] [Abstract][Full Text] [Related]
13. The prognostic value of adhesion molecule CD44v6 in women with primary breast carcinoma: a clinicopathologic study. Ma W; Deng Y; Zhou L Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):258-63. PubMed ID: 15997921 [TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 isoforms correlates with the metastatic potential of osteosarcoma. Kim HS; Park YB; Oh JH; Jeong J; Kim CJ; Lee SH Clin Orthop Relat Res; 2002 Mar; (396):184-90. PubMed ID: 11859242 [TBL] [Abstract][Full Text] [Related]
16. [Expression of the adhesion molecule CD44v6 in infiltrating ductal carcinomas of the breast is associated with hormone dependence. Our experience with 168 cases]. Ruibal A; Schneider J; del Río MC; Arias J; Núñez MI; Tejerina A Rev Esp Med Nucl; 2000 Sep; 19(5):350-5. PubMed ID: 11062111 [TBL] [Abstract][Full Text] [Related]
17. Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters. Regidor PA; Callies R; Regidor M; Günthert U; Zöller M; Schindler AE Arch Gynecol Obstet; 1996; 258(3):125-35. PubMed ID: 8781700 [TBL] [Abstract][Full Text] [Related]
18. Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients. Mayer S; zur Hausen A; Watermann DO; Stamm S; Jäger M; Gitsch G; Stickeler E J Cancer Res Clin Oncol; 2008 Nov; 134(11):1229-35. PubMed ID: 18438684 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis. Amirghofran Z; Jalali SA; Hosseini SV; Vasei M; Sabayan B; Ghaderi A J Gastrointest Cancer; 2008; 39(1-4):73-8. PubMed ID: 19333790 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer. Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]